October 2012

Retina 2012: The Innovations Continue

Robert L. Avery, MD, and Allen C. Ho, MD

Researchers Decipher the Retina's Neural Code to Create Novel Prosthetic Device

This strategy may have the capacity to restore normal or near-normal vision in patients with retinal degenerative diseases.

Callan Navitsky, Associate Editor

Opportunities and Risks in Health Care Reform

ACOs, CINs, insurance exchanges, and other future possibilities.

Paul Sternberg, MD

Surgical Tips for the Beginning Vitreoretina Fellow: How to Get the Best View During Surgery

interview with Andre J. Witkin, MD; Joseph Maguire, MD; and Sunir Garg, MD

Adopting and Adapting Imaging Tools for Clinical Use

Aron Shapiro and Ashley Lafond

Chandelier Lighting During Vitreoretinal Surgery

This form of endoillumination may be beneficial in several surgical scenarios.

Matthew T. Witmer, MD, and R.V. Paul Chan, MD

Uses of Steroids in Vitreoretinal Surgery

Stanislao Rizzo, MD, and Francesco Barca, MD

Management of Advanced Retinoblastoma With Intraarterial Chemotherapy

Marina L. Reppucci, BA; Enzo M. Fulco, MD; and Carol L. Shields, MD

A Changing Treatment Paradigm for Vitreomacular Adhesion

An interview with Julia A. Haller, MD

A Novel Intravitreal Injection System

The Guarded Injection Device provides an extra layer of protection for injections without a lid speculum.
Reviewed by Alexander M. Eaton, MD

A Microscope-Integrated OCT System for True Intrasurgical OCT Acquisition

Intraoperative OCT may introduce new surgical techniques and improve understanding of surgical outcomes.

Paul Hahn, MD, PhD, and Cynthia A. Toth, MD

Advances Reported at ARVO for the Genetics of AMD

Alan Franklin, MD, PhD

Oral Danazol for DME

David Bar-Or, MD; Gregory Thomas, BS; Kristin Salottolo, MPH; Alessandro Orlando, MPH; and Vaughan Clift, MD

Stereotactic Radiotherapy: Results of the INTREPID Study

Treatment reduced the need for anti-VEGF injections over 1 year.

Timothy L. Jackson, PhD, FRCOphth

Integrin Peptide Therapy

A new class of treatment for patients with vascular eye disease.
Reviewed by David Boyer, MD

Peripheral Ischemia and Rebound Edema in RVO

In some patients, a different approach may be needed to break the rebound cycle.

Michael A. Singer, MD; Colin S. Tan, MBBS, FRCSEd (Ophth), MMed (Ophth); and SriniVas R. Sadda, MD

The Management of Intraocular Lymphoma R esistant to Intravitreal Methotrexate Injection

In a patient who presented with asymmetric involvement in both eyes, each eye responded to different management strategies.

Pradeep Venkatesh, MD; Varun Gogoi, MD; Sumit Khanduja, MD; Lalit Kumar, MD; and Satpal Garg, MD

The Versatility of SD-OCT in Patient Screening

The use of this imaging modality has become more widespread.

Urs Vossmerbaumer, MD, PD, MSc, FEBO, DIU

Innovations

5Q With William Tasman, MD

Dr. Tasman, the Founder of Mid Atlantic Retina, practices at Wills Eye Institute, where he served as Ophthalmologist-in-Chief for 22 years. He is currently Professor and Emeritus Chairman of Ophthalmology at Jefferson Medical College in Philadelphia.